VET CBD Cannabis Brand Logo

VET CBD

Data Snapshot: Jun 01, 2026
$100K+

May-2026

Sales

Decline

Trend

6-Month

14

Product Count

SKUs

$43.01

Avg Price

-12.3%

YoY Sales Change

-2.6%

YoY Price Change

VetCBD, a renowned marijuana brand based in California, has earned a reputation for its high-quality cannabis tinctures since its inception in 2015. Established and operated by icons in the cannabis industry, VetCBD leverages premium CBD-rich cannabis extract and organic extra virgin olive oil in its therapeutic products, which are duly tested and formulated for quality assurance. Primarily focusing on non-psychoactive cannabis for pets, the brand's proprietary 20:1 CBD:THC formulation has won awards and is trusted by pet owners for delivering therapeutic benefits.
VET CBD Sales

Market Insights Snapshot

VET CBD Historical Sales by Category

In May 2026, VET CBD remained concentrated in Tincture & Sublingual with a 94.98% share, while Edible accounted for 5.02%, indicating a narrow category footprint alongside an overall brand sales year-over-year decline of 12.31% and a 24‑month decline of 15.42%. Within Tincture & Sublingual, sales fell 11.67% year over year and 3.82% month over month, whereas Edible contracted 22.88% year over year but grew 11.95% month over month, and average price across the brand decreased 2.61% year over year to $43.01. This mix and directional divergence imply the brand is reliant on a single category that is contracting year over year while a small Edible foothold is becoming a modest month-over-month offset rather than a growth engine.

Holding rank 4 in Tincture & Sublingual in California while the category declined 11.67% year over year suggests defensible placement but rising pressure if contraction persists, especially with a 3.82% month-over-month dip in the core. The 11.95% month-over-month lift in Edible alongside its 5.02% share indicates incremental headroom without immediate scale impact, and the 2.61% year-over-year average price decrease signals a price-to-mix shift rather than volume-led expansion. Together, these shifts imply the brand’s positioning hinges on stabilizing the Tincture & Sublingual base in California while selectively amplifying Edible where month-over-month traction can diversify risk without diluting the core rank.

May-2026 Rank
Edible
Tincture & Sublingual
38
4
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Tincture & Sublingual
95.0%
$47.42
-11.7%
-3.8%
Edible
5.0%
$15.57
-22.9%
+11.9%
VET CBD

Competitive Landscape

VET CBD holds rank #4 in CA Tincture & Sublingual in May 2026, unchanged from #4 in May 2025, while the category’s top tier is also static with Papa & Barkley steady at #1 and Yummi Karma unmoved at #2; notably, competitor sales trends are negative, including -13.3% year over year for Papa & Barkley and -7.6% for Yummi Karma, while Care By Design sits at #3 with -20.2% and ABX / AbsoluteXtracts improved in rank from #6 to #5 despite -12.5% sales year over year. With VET CBD flat at #4 across the last three months and at its peak rank in May 2026, the unchanging placement alongside declining competitor sales implies a stable share position that could convert into upward mobility if even small incremental gains materialize.

VET CBD market ranking for CA Tincture & Sublingual

VET CBD

Notable Products

The steepest movement in May 2026 was the CBD/THC 10:1 Extra Strength Tincture (250mg CBD, 25mg THC, 60ml, 2oz) plunging 50.7% MoM to rank 9 while the CBD/THC 20:1 Regular Strength Tincture (1000mg CBD, 50mg THC, 2oz, 60ml) fell 17.4% to rank 3. Offsetting that, the CBD/THC 20:1 Regular Strength Tincture (250mg CBD, 12.5mg THC, 60ml, 2oz) grew 19.6% MoM to hold rank 1 and the 10:1 Extra Strength Tincture (500mg CBD, 50mg THC, 60ml, 2oz) rose 13.5% at rank 4, indicating shopper preference consolidating around higher-volume regular-strength formats over mid-potency variants. Four of the top ten are Tincture & Sublingual SKUs concentrated in the 20:1 ratio, while Edible chews mixed signals with the Peanut Butter 30-Pack up 43.2% at rank 6 and the 60-Pack down 4.2% at rank 8; the top 250mg 20:1 tincture generated $50,285, reinforcing the tilt toward entry-strength CBD-forward ratios. The pattern implies VET CBD’s commercial direction is skewing toward 20:1 regular-strength tinctures as the demand spine, with selective pet and wellness chews serving as incremental rather than core volume drivers.

Product
Category
Jan-2026
Feb-2026
Mar-2026
Apr-2026
May-2026
MoM %
CBD/THC 20:1 Regular Strength Tincture (250mg CBD, 12.5mg THC, 60ml, 2oz)
Tincture & Sublingual
2
1
1
1
1
+19.6%
CBD/THC 20:1 Regular Strength Tincture (125mg CBD, 6.25mg THC, 1oz, 30ml)
Tincture & Sublingual
1
2
2
1
2
+3.1%
CBD/THC 20:1 Regular Strength Tincture (1000mg CBD, 50mg THC, 2oz, 60ml)
Tincture & Sublingual
3
3
5
2
3
-17.4%
CBD/THC 10:1 Extra Strength Tincture (500mg CBD, 50mg THC, 60ml, 2oz)
Tincture & Sublingual
4
5
3
4
4
+13.5%
CBD/THC 20:1 Extra Strength Pet Tincture (250mg CBD, 25mg THC, 60ml, 2oz)
Tincture & Sublingual
6
4
6
3
5
-10.6%
CBD Calming Peanut Butter Soft Chews 30-Pack (150mg CBD)
Edible
7
7
7
6
6
+43.2%
CBD/THC 20:1 Regular Strength Tincture (500mg CBD, 25mg THC, 60ml, 2oz)
Tincture & Sublingual
5
6
4
5
7
-22.9%
CBD Calming Peanut Butter Soft Chews 60-Pack (300mg CBD)
Edible
>10
>10
9
8
8
-4.2%
CBD/THC 10:1 Extra Strength Tincture (250mg CBD, 25mg THC, 60ml, 2oz)
Tincture & Sublingual
8
8
8
7
9
-50.7%
CBD Mobility Soft Chews 30-Pack (150mg CBD)
Edible
9
10
>10
9
10
+23.1%
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market